Cervical Cancer Vaccine Sayville NY

The human papillomavirus (HPV) vaccine works for women aged 24 to 45 in Sayville who aren't already infected by HPV, the virus that has been linked to cervical cancer and other cervical diseases. That's the finding from Dr. Nubia Munoz, of the National Institute of Cancer in Bogota, Columbia, who noted that women's rising age at first marriage and increasing divorce rates have led to more widespread premarital intercourse and pairing with new sexual partners around middle age.

Local Companies

SHABEER DAR, MD
(631) 376-1101
400 Montauk Highway
West Islip, NY
Shabeer A Dar, MD
631-376-1101
400 Montauk Hwy Ste 108
West Islip, NY
Min Janice Lu, MD
212-263-6485
Hsc T 16 Rppm 020,
Stony Brook, NY
Alexander A Tocher, MD
595 Route 25a
Miller Place, NY
Birjis Akhun, MD
516-425-2280
180 E Pulaski Rd
Huntington Station, NY
EMMANUEL SYGACO, MD
(631) 422-4545
435 Montauk Highway
West Islip, NY
DEVINA PRAKASH, MD
(631) 444-2585
University Hospital
Stony Brook, NY
Evan Roy Berger, MD
631-751-3000
235 N Belle Mead Rd
East Setauket, NY
Devina Prakash, MD
631-444-7720
100 Nicolls Rd
Stony Brook, NY
Martin J Silverstein, MD
631-751-3000
181 N Belle Mead Rd
East Setauket, NY
Data Provided by:
  

Provided By:

TUESDAY, June 2 (HealthDay News) -- The human papillomavirus (HPV) vaccine works for women aged 24 to 45 who aren't already infected by HPV, the virus that has been linked to cervical cancer and other cervical diseases.

That's the finding from Dr. Nubia Munoz, of the National Institute of Cancer in Bogota, Columbia, who noted that women's rising age at first marriage and increasing divorce rates have led to more widespread premarital intercourse and pairing with new sexual partners around middle age.

Their study included more than 3,200 women, aged 24 to 45, with no history of cervical disease or cancer or genital warts caused by HPV types 6, 11, 16 and 18. The women received either the quadrivalent HPV vaccine, which protects against the four HPV types, or a placebo at day one and months two and six of the study.

The women were followed for about 2.2 years and the researchers identified four cases of infection or disease in the vaccinated group, compared to 41 cases in the placebo group. That means the vaccine was 91 percent effective against all four virus strains.

When they looked at only HPV types 16 and 18, the researchers found four cases in the vaccine group and 23 in the placebo group, which means the vaccine was 83 percent effective against those two HPV types.

"Lower effectiveness detected in the mixed population (susceptible women and those who have already acquired HPV infection or HPV-associated disease) suggests that the public health effect of vaccinating women aged 25 to 45 years will be smaller than that recorded after vaccinating susceptible adolescents. This notion will be assessed in future cost-benefit analyses," the study authors wrote.

The findings appear online June 2 and in an upcoming print issue of The Lancet.

More information

The U.S. National Cancer Institute has more about HPV vaccines.

SOURCE: The Lancet, news release, June 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Exercise for Prostate Cancer Sayville NY
Regular exercise may help protect men from prostate cancer, says a new study. U.S. researchers looked at 190 men who had a prostate biopsy and found that those who were moderately active -- anything equivalent to walking at a moderate pace for several hours a week -- were significantly less likely to be diagnosed with prostate cancer.
- Colon Cancer Prevention Sayville NY
- Folic Acid Preventing Breast Cancer Sayville NY
- Follow Up After Skin Cancer Sayville NY
- Breast Cancer Treatment Sayville NY
- Risks for Childhood Cancer Survivors Sayville NY
- Delayed Prostate Cancer Therapy Sayville NY
- HPV and Cervical Cancer Sayville NY
- Fertility in Ovarian Cancer Patients Sayville NY